Global CGM Market is forecast to cross more than US$ 4 Billion by the year 2024

About This Presentation
Title:

Global CGM Market is forecast to cross more than US$ 4 Billion by the year 2024

Description:

For More Info: Renub Research predicts that, by the year 2024, Global CGM market is forecast to cross more than US$ 4 Billion. Continuous Glucose Monitoring (CGM) systems are the new innovation in diabetes management. In Contrast, to traditional systems that allow for one time check of glucose levels, a CGM device notifies the user if the glucose level nears current levels. The device measures glucose from the tissues as contrasting to manual testing of blood by a finger-stick glucose meter assists in recognizing glucose levels for a longer period, while performing dissimilar activities. Diabetes is a main worldwide concern that, as International Diabetes Federation (IDF) asserts, affects around 415 million populations in 2015. Effectual management of diabetes is crucial, especially considering the inactive lifestyle that most of the people around the globe have engaged. – PowerPoint PPT presentation

Number of Views:6

less

Transcript and Presenter's Notes

Title: Global CGM Market is forecast to cross more than US$ 4 Billion by the year 2024


1
Global CGM Market
Category Medical Devices
2
Global CGM Market Forecast Analyst View Renub
Research predicts that, by the year 2024, Global
CGM market is forecast to cross more than US 4
Billion. Get 10 Free Customization in this
Report Press Release Title Global CGM market
is forecast to cross more than US 4 Billion by
the year 2024 For More Information http//www.re
nub.com/global-cgm-market-users-reimbursement-poli
cy-continuous-glucose-monitoring-p.php

3
Global CGM market will be an US 4 Billion
opportunity by 2024.
Research Report Title Global CGM Market,
Users, Reimbursement Policy, CGM Components
(Glucose Sensor, Transmitter) Market, Diabetes
(Type1 2) Population, Forecast Download Full
Report http//www.renub.com/global-cgm-market-us
ers-reimbursement-policy-continuous-glucose-monito
ring-p.php Renub Research predicts that, by the
year 2024, Global CGM market is forecast to cross
more than US 4 Billion. Continuous Glucose
Monitoring (CGM) systems are the new innovation
in diabetes management. In Contrast, to
traditional systems that allow for one time check
of glucose levels, a CGM device notifies the user
if the glucose level nears current levels. The
device measures glucose from the tissues as
contrasting to manual testing of blood by a
finger-stick glucose meter assists in recognizing
glucose levels for a longer period, while
performing dissimilar activities.

4
At present CGM is reimbursed for pediatric,
gestational diabetes and Type 1 diabetes patients
in some countries and it is expected that it will
be accessible to all diabetes patients in due
course of time.
Diabetes is a main worldwide concern that, as
International Diabetes Federation (IDF) asserts,
affects around 415 million populations in 2015.
Effectual management of diabetes is crucial,
especially considering the inactive lifestyle
that most of the people around the globe have
engaged. Continuous glucose monitoring (CGM)
systems present the efficient solution in
diabetes management through continuous real-time
glucose monitoring.  Renub Research latest
study Global CGM Market, Users, Reimbursement
Policy, CGM Components (Glucose Sensor,
Transmitter) Market, Diabetes (Type1 2)
Population, Forecast provides a detailed and
comprehensive insight of the Global CGM Market.
Request a free sample copy of the
report http//www.renub.com/contactus.php  

5
Global CGM market will be an US 4 Billion
opportunity by 2024.
Behind safety evidence for CGM systems, rising
awareness, and emergent demand are major factors
driving demand around the globe. Conversely,
soaring prices of these systems and the rather
awkward experience of wearing of these relatively
prominent gadgets all the day are currently
limiting its demand in the middle income and Poor
Countries, where there is insufficient
penetration of services and healthcare IT
products. Report emphasizes on Glucose Sensors
CGM transmitters The report studied the CGM
market and it has been divided into 2 components
i.e. Glucose Sensors and CGM transmitters.
Transmitters receivers along with sensors are
known as standalone CGM systems, which are
preinstalled by the manufacturer. Sensors are not
reusable items, so after every 5 to 7 days it
should be replaced.  In CGM system, Sensor is
an integral part. The compassion and type of the
sensor are vital factors that influence the
accuracy of sensing glucose level in the
interstitial fluid. While, Transmitters grasp a
leading share, accounting for over 50 (2015) of
the market share, revenue contribution of the
sensors segment is estimated to add the faster
rate during the anticipated period (2017
2024).

6
According to many experts, CGM is the best device
for proper diabetes management for those having
severe diabetes complications occurred
periodically.
Soaring Prices of CGM devices affects Low Income
Nations International Diabetes Federation (IDF)
asserts that approximately 75 of the diabetic
population lives in lower and middle income
nations like India, China, Japan and Israel.
Almost 50 of the worldwide diabetic population
in 2015, in Asia-Pacific regions with occurrence
rate being the maximum in India and China. Market
penetration in these countries is relatively low,
mainly due to high prices of CGM devices.
Conversely, the scenario in Asia Pacific region
is expected to change in the coming years because
of the rising patient awareness and falling down
prices of these systems. This would change the
industry dynamics and impact the market growth
positively. United States dominates the CGM
Market Globally  CGM (Continuous Glucose Monitor)
is an extremely relevant to almost all age groups
to manage diabetes efficiently and effectively.
The United States controls the global CGM Market.
In Europe Germany and France, CGM market has
grown to a noticeable strength. According to many
experts, CGM is the best device for proper
diabetes management for those having severe
diabetes complications occurred periodically.

7
At present, CGM is reimbursed for pediatric,
gestational diabetes and Type 1 diabetes patients
in some countries and it is expected that it will
be accessible to all diabetes patients in due
course of time.
Reimbursement policy in Distinguished
Nations  CGM reimbursement is still in its
infancy stages in many countries but the policy
has been expanding over a period of time and
addition of technological device under diabetes
management is implemented by many countries. At
present, CGM is reimbursed for pediatric,
gestational diabetes and Type 1 diabetes patients
in some countries and it is expected that it will
be accessible to all diabetes patients in due
course of time. As countries are continuously
expanding their diabetes management policy and
several positive assessments are being done in
favor of CGM it is expected to drive the market
in future.  

8
Table of Contents for Global CGM Market
Table of Contents 1. Executive Summary 2.
Global CGM User (2010 - 2024) 3. Global CGM
Market Forecast (2010 - 2024) 4. By
Components CGM Market (2010 - 2024) 5. Market
Share By Countries 6. Global CGM (Continuous
Glucose Monitoring) Reimbursement Model 7.
Abbott Freestyle Libre vs CGM (Continuous Glucose
Monitoring) 8. United States Diabetes
Population (2010 - 2024) 9. United States CGM
Market Forecast 10. United States CGM User
(2010 - 2024) 11. CGM Reimbursement in United
States 12. United Kingdom Diabetes Population
(2010 - 2024) 13. United Kingdom CGM Market
Forecast 14. United Kingdom CGM User (2010 -
2024)

9
Table of Contents for Global CGM Market
15. CGM Reimbursement in United Kingdom 16.
Israel Diabetes Population (2010 - 2024) 17.
Israel CGM Market Forecast 18. Israel CGM
User (2010 - 2024) 19. CGM Reimbursement in
Israel 20. Germany Diabetes Population (2010 -
2024) 21. Germany CGM Market Forecast 22.
Germany CGM User (2010 - 2024) 23. CGM
Reimbursement in Germany 24. Netherlands
Diabetes Population (2010 - 2024) 25.
Netherlands CGM Market Forecast 26.
Netherlands CGM User (2010 - 2024) 27. CGM
Reimbursement in Netherlands 28. Sweden
Diabetes Population (2010 - 2024) 29. Sweden
CGM Market Forecast 30. Sweden CGM User
(2010 - 2024)

10
Table of Contents for Global CGM Market
31. CGM Reimbursement in Sweden 32. France
Diabetes Population (2010 - 2024) 33. France
CGM Market Forecast 34. France CGM User
(2010 - 2024) 35. CGM Reimbursement in
France 36. Switzerland Diabetes Population
(2010 - 2024) 37. Switzerland CGM Market
Forecast 38. Switzerland CGM User (2010 -
2024) 39. CGM Reimbursement in Switzerland 40.
Australia Diabetes Population (2010 -
2024) 41. Australia CGM Market Forecast 42.
Australia CGM User (2010 - 2024) 43. CGM
Reimbursement in Australia 44. Japan Diabetes
Population (2010 - 2024) 45. Japan CGM Market
Forecast

11
Table of Contents for Global CGM Market
46. Japan CGM User (2010 - 2024) 47. CGM
Reimbursement in Japan 48. Canada Diabetes
Population (2010 - 2024) 49. Canada CGM Market
Forecast 50. Canada CGM User (2010 -
2024) 51. CGM Reimbursement in Canada 52.
Market Dynamics

12
Get 10 Free Customization in this Report
Medical Devices Reports http//www.renub.com/medi
cal-devices-15-c.php
Renub Research - North America Rajat Gupta 225 Kristie Ln, Roswell Georgia 30076, United States Tel 1-678-302-0700 Email info_at_renub.com www.renub.com Renub Research - Asia Ankit Mishra C 86, Sector 10 Noida 201301, India Tel 91-120-421-9822 Email info_at_renub.com www.renub.com
Write a Comment
User Comments (0)